BICLUSTER_ID : UPREG-148
PATHOGENS /3/ : listeria monocytogenes,yersinia enterocolitica,streptococcus pyogenes
TARGETS /15/ : NFKB1, GCLM, IL12B, CCL20, JAK2, HMOX1, HSPA1B, NP, IL3RA, IL6, GCH1, SAT1, PIM1, TXNRD1, PLAUR
Gene SetLeading Edge Genes
GERY CEBP TARGETSGADD45B, HMOX1, HSPA1B, JUNB, GADD45G, CXCL5, GCH1, SAT1, PIM1
NETPATH IL 2 PATHWAY UPAHR, IFNA2, SOCS3, PIM1, TXNRD1, SLC30A1, IER3, IFIT1, NFKB1, KLF6, LIF, IL18R1, GADD45G, PTPRC, TRIM21, PRKX, IL6, RGS1, DAXX, UPP1, PLAUR, MX1
NCI IL23PATHWAYNFKB1, IL12B, CXCL1, JAK2, IL18R1, SOCS3, IL6, CXCL9
NETPATH IL 1 PATHWAY UPCCL20, LIF, CXCL1, NP, PRG1, CXCL5, IL6, ZFP36, MT2A, CXCL2, TXNRD1, PTX3
NETPATH IL 5 PATHWAY UPNFKB1, IL3RA, GCLM, PLSCR1, UPP1, CASP4, IER3
NETPATH IL 4 PATHWAY DOWNIL6, CCL20, GADD45B, CXCL2, MX1, GBP2
NETPATH IL 3 PATHWAY UPIL3RA, SOCS3, CCL7, PIM1
NETPATH IL 6 PATHWAY UPSOCS3, GADD45B, ZFP36, JUNB, PIM1, MAP3K8, MX1
BIOCARTA IL10 PATHWAY
BIOCARTA STEM PATHWAY
BIOCARTA NFKB PATHWAY
MAHAJAN RESPONSE TO IL1A UP
KEGG GRAFT VERSUS HOST DISEASE
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D UP
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION B
KRASNOSELSKAYA ILF3 TARGETS UP
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
RADAEVA RESPONSE TO IFNA1 UP
LUI THYROID CANCER CLUSTER 4
HOFMANN CELL LYMPHOMA DN
XU HGF TARGETS REPRESSED BY AKT1 UP
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
NETPATH IL 7 PATHWAY UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
BROWNE INTERFERON RESPONSIVE GENES
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
ROETH TERT TARGETS UP
HINATA NFKB TARGETS KERATINOCYTE UP
MARKEY RB1 ACUTE LOF UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
XU AKT1 TARGETS 6HR
OSADA ASCL1 TARGETS DN
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
DELYS THYROID CANCER UP
KRISHNAN FURIN TARGETS UP
POOLA INVASIVE BREAST CANCER UP
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
LIU VAV3 PROSTATE CARCINOGENESIS UP
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
BROWNE HCMV INFECTION 6HR UP
BIOCARTA FREE PATHWAY
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
BIOCARTA RANKL PATHWAY
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
LIAN LIPA TARGETS 6M
MCLACHLAN DENTAL CARIES UP
JAATINEN HEMATOPOIETIC STEM CELL DN
ISHIKAWA STING SIGNALING
TAVOR CEBPA TARGETS UP
LEE LIVER CANCER E2F1 UP
FOSTER INFLAMMATORY RESPONSE LPS DN
GAURNIER PSMD4 TARGETS
HELLER SILENCED BY METHYLATION UP
FARMER BREAST CANCER CLUSTER 1
GRANDVAUX IFN RESPONSE NOT VIA IRF3
BOWIE RESPONSE TO TAMOXIFEN
HADDAD T LYMPHOCYTE AND NK PROGENITOR DN
NETPATH TNF ALPHA PATHWAY UP
MARKEY RB1 CHRONIC LOF DN
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
GESERICK TERT TARGETS DN
NOJIMA SFRP2 TARGETS DN
AMIT SERUM RESPONSE 120 MCF10A
LEE LIVER CANCER MYC E2F1 UP
NCI IL1PATHWAY
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
GEISS RESPONSE TO DSRNA UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC DN
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
NETPATH IL 2 PATHWAY
NCI IL12 2PATHWAY
TIAN TNF SIGNALING VIA NFKB
GRUETZMANN PANCREATIC CANCER UP
ZHU CMV ALL UP
KEGG SYSTEMIC LUPUS ERYTHEMATOSUS
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
AMIT DELAYED EARLY GENES
HUANG DASATINIB RESISTANCE UP
HINATA NFKB TARGETS FIBROBLAST UP
RHEIN ALL GLUCOCORTICOID THERAPY UP
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
NOJIMA SFRP2 TARGETS UP
CHEN HOXA5 TARGETS 6HR UP
MISSIAGLIA REGULATED BY METHYLATION UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
ZHANG INTERFERON RESPONSE
CHANG IMMORTALIZED BY HPV31 DN
KEGG ASTHMA
AUJLA IL22 AND IL17A SIGNALING
SA MMP CYTOKINE CONNECTION
WU CELL MIGRATION
WALLACE PROSTATE CANCER RACE UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
SIMBULAN UV RESPONSE NORMAL UP
KHETCHOUMIAN TRIM24 TARGETS UP
KIM LRRC3B TARGETS
SINGH NFE2L2 TARGETS
DACOSTA ERCC3 ALLELE XPCS VS TTD UP
COATES MACROPHAGE M1 VS M2 DN
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
UROSEVIC RESPONSE TO IMIQUIMOD
TSAI RESPONSE TO RADIATION THERAPY
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
KEGG JAK STAT SIGNALING PATHWAY
KEGG PRION DISEASES
HARRIS HYPOXIA
NETPATH KIT RECEPTOR PATHWAY UP
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
TSAI DNAJB4 TARGETS UP
DER IFN BETA RESPONSE UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
AMIT EGF RESPONSE 20 HELA
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
DIAZ CHRONIC MEYLOGENOUS LEUKEMIA DN
BASSO CD40 SIGNALING UP
MARZEC IL2 SIGNALING UP
SOUCEK MYC TARGETS
BIOCARTA DC PATHWAY
BOYLAN MULTIPLE MYELOMA C D DN
BILBAN B CLL LPL DN
WANG ESOPHAGUS CANCER VS NORMAL UP
NCI PTP1BPATHWAY
WU HBX TARGETS 2 DN
MAHADEVAN RESPONSE TO MP470 UP
ZHAN MULTIPLE MYELOMA LB DN
KEGG AUTOIMMUNE THYROID DISEASE
GOLDRATH ANTIGEN RESPONSE
KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY
SANA RESPONSE TO IFNG UP
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
KEGG LEISHMANIA INFECTION
DER IFN ALPHA RESPONSE UP
WU HBX TARGETS 1 UP
EINAV INTERFERON SIGNATURE IN CANCER
MCLACHLAN DENTAL CARIES DN
KEGG ALLOGRAFT REJECTION
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
BROWNE HCMV INFECTION 4HR UP
WONG ENDOMETRIAL CANCER LATE
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
ZHU CMV 8 HR UP
BIOCARTA INFLAM PATHWAY
SANA TNF SIGNALING UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D UP
NCI IL27PATHWAY
MOSERLE IFNA RESPONSE
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
FOSTER INFLAMMATORY RESPONSE LPS UP
BIOCARTA ASBCELL PATHWAY
ONDER CDH1 TARGETS 2 DN
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
KEGG HEMATOPOIETIC CELL LINEAGE
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
LIAN LIPA TARGETS 3M
KEGG CYTOSOLIC DNA SENSING PATHWAY
JISON SICKLE CELL DISEASE UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
DASU IL6 SIGNALING UP
AMIT EGF RESPONSE 120 MCF10A
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
GOUYER TATI TARGETS UP
ZUCCHI METASTASIS DN
LU IL4 SIGNALING
PRAMOONJAGO SOX4 TARGETS UP
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
yersinia enterocolitica p60 bl6listeria monocytogenesstreptococcus pyogenesGeneSet Name
0.00040 0.00163 0.01652GERY_CEBP_TARGETS
0.00994 0.00068 0.01602NETPATH_IL_2_PATHWAY_UP
0.00000 0.00100 0.00014NCI_IL23PATHWAY
0.00000 0.00000 0.03192NETPATH_IL_1_PATHWAY_UP
0.00711 0.00007 0.03974NETPATH_IL_5_PATHWAY_UP
0.00146 0.00001 0.00471NETPATH_IL_4_PATHWAY_DOWN
0.00000 0.00553 0.00095NETPATH_IL_3_PATHWAY_UP
0.00000 0.00233 0.00001NETPATH_IL_6_PATHWAY_UP
0.00108 0.00014 0.03771BIOCARTA_IL10_PATHWAY
0.03650 0.05829 0.03626BIOCARTA_STEM_PATHWAY
0.05121 0.08391 0.16684BIOCARTA_NFKB_PATHWAY
0.00010 0.00046 0.17839MAHAJAN_RESPONSE_TO_IL1A_UP
0.00069 0.00003 0.01019KEGG_GRAFT_VERSUS_HOST_DISEASE
0.00007 0.00069 0.08562TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.00011 0.00001 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.04211 0.09679 0.00784TENEDINI_MEGAKARYOCYTE_MARKERS
0.04591 0.00437 0.02304LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00309 0.00001 0.00396KRASNOSELSKAYA_ILF3_TARGETS_UP
0.00297 0.04054 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00029 0.00000 0.00032LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.00709 0.00000 0.00000RADAEVA_RESPONSE_TO_IFNA1_UP
0.17950 0.03364 0.02400LUI_THYROID_CANCER_CLUSTER_4
0.17985 0.09034 0.00273HOFMANN_CELL_LYMPHOMA_DN
0.09778 0.07527 0.14382XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.00618 0.00007 0.00020BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.00709 0.09197 0.04416NETPATH_IL_7_PATHWAY_UP
0.00184 0.00000 0.11415THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.00006 0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.00735 0.01807 0.01268TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.00708 0.00008 0.13253TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.09575 0.00096 0.00062ROETH_TERT_TARGETS_UP
0.00000 0.00001 0.05930HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.01647 0.00004 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.00058 0.00736 0.02604KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00129 0.00065 0.01569XU_AKT1_TARGETS_6HR
0.08169 0.04416 0.03178OSADA_ASCL1_TARGETS_DN
0.00356 0.00000 0.10005NUYTTEN_EZH2_TARGETS_UP
0.00201 0.01422 0.02575DUTTA_APOPTOSIS_VIA_NFKB
0.05105 0.05915 0.13519DELYS_THYROID_CANCER_UP
0.13887 0.04616 0.01866KRISHNAN_FURIN_TARGETS_UP
0.00857 0.01413 0.00003POOLA_INVASIVE_BREAST_CANCER_UP
0.00018 0.00199 0.00616DIRMEIER_LMP1_RESPONSE_EARLY
0.14426 0.00068 0.00000DER_IFN_GAMMA_RESPONSE_UP
0.13918 0.00181 0.00394KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.12805 0.01016 0.00000LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.00069 0.00001 0.00000SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.00079 0.00000 0.00004BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.00305 0.00045 0.13305BROWNE_HCMV_INFECTION_6HR_UP
0.18018 0.08760 0.10876BIOCARTA_FREE_PATHWAY
0.06839 0.00000 0.18510RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.02528 0.00001 0.00012NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.07528 0.17317 0.08751BIOCARTA_RANKL_PATHWAY
0.10917 0.01127 0.01028NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00177 0.00075 0.00004LIAN_LIPA_TARGETS_6M
0.00050 0.00000 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.00289 0.04089 0.00039JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.02216 0.02022 0.08747ISHIKAWA_STING_SIGNALING
0.06979 0.00125 0.00445TAVOR_CEBPA_TARGETS_UP
0.00563 0.02021 0.01561LEE_LIVER_CANCER_E2F1_UP
0.00000 0.00001 0.00568FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00000 0.00001 0.00000GAURNIER_PSMD4_TARGETS
0.00251 0.07324 0.00113HELLER_SILENCED_BY_METHYLATION_UP
0.00711 0.00001 0.00000FARMER_BREAST_CANCER_CLUSTER_1
0.00375 0.00061 0.00000GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.00593 0.00001 0.00016BOWIE_RESPONSE_TO_TAMOXIFEN
0.05879 0.06328 0.00503HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN
0.17984 0.00123 0.03392NETPATH_TNF_ALPHA_PATHWAY_UP
0.00471 0.00005 0.00039MARKEY_RB1_CHRONIC_LOF_DN
0.00015 0.00011 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.00018 0.12803 0.05508SMID_BREAST_CANCER_LUMINAL_B_DN
0.00000 0.00000 0.06782ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.00000 0.02216 0.01538GESERICK_TERT_TARGETS_DN
0.01777 0.02237 0.01391NOJIMA_SFRP2_TARGETS_DN
0.00007 0.00040 0.09332AMIT_SERUM_RESPONSE_120_MCF10A
0.00848 0.02477 0.01825LEE_LIVER_CANCER_MYC_E2F1_UP
0.04794 0.00886 0.19947NCI_IL1PATHWAY
0.00000 0.00000 0.01128VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.04624 0.00001 0.00074BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.00109 0.00027 0.01876GEISS_RESPONSE_TO_DSRNA_UP
0.17431 0.04120 0.08427TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN
0.00272 0.00032 0.19908GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.00070 0.07166 0.01687SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.10305 0.09380 0.01425NETPATH_IL_2_PATHWAY
0.00272 0.04187 0.00000NCI_IL12_2PATHWAY
0.00016 0.00054 0.00455TIAN_TNF_SIGNALING_VIA_NFKB
0.11422 0.00031 0.02643GRUETZMANN_PANCREATIC_CANCER_UP
0.03630 0.00000 0.06342ZHU_CMV_ALL_UP
0.17945 0.00001 0.02679KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.01680 0.02242 0.00011KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.06744 0.00200 0.11718AMIT_DELAYED_EARLY_GENES
0.00029 0.07424 0.04595HUANG_DASATINIB_RESISTANCE_UP
0.00034 0.00031 0.14412HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.19873 0.00045 0.01655RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.00000 0.02915 0.00010KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.00037 0.02668 0.08281NOJIMA_SFRP2_TARGETS_UP
0.01499 0.00069 0.12534CHEN_HOXA5_TARGETS_6HR_UP
0.00038 0.00001 0.01557MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.02220 0.00015 0.01265SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00037 0.00000 0.00000ZHANG_INTERFERON_RESPONSE
0.03094 0.00167 0.02148CHANG_IMMORTALIZED_BY_HPV31_DN
0.02752 0.00022 0.01985KEGG_ASTHMA
0.00953 0.00510 0.02059AUJLA_IL22_AND_IL17A_SIGNALING
0.01474 0.04438 0.02244SA_MMP_CYTOKINE_CONNECTION
0.00037 0.00267 0.05956WU_CELL_MIGRATION
0.00029 0.00031 0.00000WALLACE_PROSTATE_CANCER_RACE_UP
0.00069 0.00001 0.00854TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.13433 0.04183 0.01756SIMBULAN_UV_RESPONSE_NORMAL_UP
0.05355 0.10702 0.00010KHETCHOUMIAN_TRIM24_TARGETS_UP
0.03216 0.00001 0.00000KIM_LRRC3B_TARGETS
0.05754 0.00052 0.05524SINGH_NFE2L2_TARGETS
0.06442 0.10505 0.13522DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.00342 0.14232 0.01553COATES_MACROPHAGE_M1_VS_M2_DN
0.13271 0.00000 0.02986RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.00167 0.00008 0.00001UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.01450 0.05481 0.02614TSAI_RESPONSE_TO_RADIATION_THERAPY
0.00504 0.07558 0.01836CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.00000 0.00000 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00111 0.17844 0.00074KEGG_JAK_STAT_SIGNALING_PATHWAY
0.01379 0.00194 0.07387KEGG_PRION_DISEASES
0.00029 0.00000 0.15102HARRIS_HYPOXIA
0.00015 0.05671 0.02708NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.02263 0.00000 0.00016FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.06839 0.01474 0.00073TSAI_DNAJB4_TARGETS_UP
0.04762 0.00000 0.00032DER_IFN_BETA_RESPONSE_UP
0.02538 0.00000 0.19929DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.18824 0.02894 0.10732AMIT_EGF_RESPONSE_20_HELA
0.00040 0.00061 0.00580TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.19613 0.00001 0.00046DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.00018 0.00020 0.00023BASSO_CD40_SIGNALING_UP
0.00021 0.00507 0.13526MARZEC_IL2_SIGNALING_UP
0.00018 0.09270 0.00021SOUCEK_MYC_TARGETS
0.04231 0.00005 0.01251BIOCARTA_DC_PATHWAY
0.01871 0.12871 0.00075BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.00270 0.01132 0.04441BILBAN_B_CLL_LPL_DN
0.03028 0.17037 0.02328WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.10130 0.07255 0.10487NCI_PTP1BPATHWAY
0.16824 0.00791 0.02682WU_HBX_TARGETS_2_DN
0.00018 0.00004 0.01593MAHADEVAN_RESPONSE_TO_MP470_UP
0.02608 0.00177 0.00000ZHAN_MULTIPLE_MYELOMA_LB_DN
0.01127 0.00296 0.00071KEGG_AUTOIMMUNE_THYROID_DISEASE
0.19042 0.04561 0.04429GOLDRATH_ANTIGEN_RESPONSE
0.06399 0.05669 0.01314KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.01462 0.00000 0.00000SANA_RESPONSE_TO_IFNG_UP
0.00000 0.00001 0.00099LIANG_SILENCED_BY_METHYLATION_2
0.06189 0.00016 0.00038DAUER_STAT3_TARGETS_UP
0.07814 0.00055 0.00061KEGG_LEISHMANIA_INFECTION
0.14030 0.00000 0.00000DER_IFN_ALPHA_RESPONSE_UP
0.00917 0.08533 0.18465WU_HBX_TARGETS_1_UP
0.06958 0.00000 0.00000EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.00065 0.00000 0.00000MCLACHLAN_DENTAL_CARIES_DN
0.00288 0.00001 0.03176KEGG_ALLOGRAFT_REJECTION
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00398 0.00097 0.05533GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00019 0.00001 0.06323BROWNE_HCMV_INFECTION_4HR_UP
0.04574 0.06782 0.03561WONG_ENDOMETRIAL_CANCER_LATE
0.00000 0.00000 0.00019ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00061 0.00000 0.00367ZHU_CMV_8_HR_UP
0.00000 0.00012 0.19333BIOCARTA_INFLAM_PATHWAY
0.00022 0.00000 0.00000SANA_TNF_SIGNALING_UP
0.00043 0.00004 0.00957TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.02901 0.04900 0.00027NCI_IL27PATHWAY
0.00236 0.00000 0.00000MOSERLE_IFNA_RESPONSE
0.00804 0.00306 0.11584SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.00004 0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.12689 0.00550 0.18436BIOCARTA_ASBCELL_PATHWAY
0.00022 0.00554 0.16233ONDER_CDH1_TARGETS_2_DN
0.00030 0.00000 0.09492HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00043 0.01434 0.00468KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.00019 0.12933 0.07017SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.00252 0.00018 0.00004LIAN_LIPA_TARGETS_3M
0.00200 0.00588 0.04007KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.06359 0.00000 0.00066JISON_SICKLE_CELL_DISEASE_UP
0.00006 0.00001 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00177 0.00595 0.04449DASU_IL6_SIGNALING_UP
0.00086 0.00423 0.12740AMIT_EGF_RESPONSE_120_MCF10A
0.00037 0.00001 0.05507GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.08058 0.06660 0.18519GOUYER_TATI_TARGETS_UP
0.04370 0.00518 0.01684ZUCCHI_METASTASIS_DN
0.00176 0.01517 0.14418LU_IL4_SIGNALING
0.02844 0.01526 0.19931PRAMOONJAGO_SOX4_TARGETS_UP